- Home
- LXU vs XNCR Comparison
LXU vs XNCR Comparison
Compare LXU & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXU
- XNCR
- Stock Information
- Founded
- LXU 1968
- XNCR 1997
- Country
- LXU United States
- XNCR United States
- Employees
- LXU N/A
- XNCR N/A
- Industry
- LXU Major Chemicals
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- LXU Industrials
- XNCR Health Care
- Exchange
- LXU Nasdaq
- XNCR Nasdaq
- Market Cap
- LXU 612.4M
- XNCR 547.8M
- IPO Year
- LXU 1969
- XNCR 2013
- Fundamental
- Price
- LXU $8.82
- XNCR $12.40
- Analyst Decision
- LXU Buy
- XNCR Buy
- Analyst Count
- LXU 3
- XNCR 11
- Target Price
- LXU $10.08
- XNCR $22.20
- AVG Volume (30 Days)
- LXU 383.9K
- XNCR 1.2M
- Earning Date
- LXU 10-28-2025
- XNCR 11-05-2025
- Dividend Yield
- LXU N/A
- XNCR N/A
- EPS Growth
- LXU N/A
- XNCR N/A
- EPS
- LXU N/A
- XNCR N/A
- Revenue
- LXU $538,851,000.00
- XNCR $146,929,000.00
- Revenue This Year
- LXU $13.46
- XNCR $23.31
- Revenue Next Year
- LXU N/A
- XNCR N/A
- P/E Ratio
- LXU N/A
- XNCR N/A
- Revenue Growth
- LXU 2.60
- XNCR N/A
- 52 Week Low
- LXU $4.88
- XNCR $6.92
- 52 Week High
- LXU $9.68
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- LXU 67.90
- XNCR 81.61
- Support Level
- LXU $7.71
- XNCR $11.36
- Resistance Level
- LXU $9.20
- XNCR $12.63
- Average True Range (ATR)
- LXU 0.32
- XNCR 0.54
- MACD
- LXU 0.12
- XNCR 0.10
- Stochastic Oscillator
- LXU 97.33
- XNCR 79.86
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.